1st Quarter - Report

ACG ADVOCACY for JUNO THERAPEUTICS, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Innovation and investment issues impacting Juno Therapeutics.

LobbyistCovered position, as disclosed
MARY O'DEA AHEARN ALLEN —
MANUS COONEY Staff Director & Chief Counsel, Senate Judiciary Committee
CHRIS ISRAEL U.S. Coordinator for International IP Enforcement; Deputy Chief of Staff, Department of Commerce; Deputy Assistant Secretary for Tech Policy, Department of Commerce
JULIE PHILP LD, Rep. John Campbell; LA/Senior LA, Rep. Gil Gutknecht; LA and Scheduler, Rep. Michael Burgess; LA, Scheduler, Rep. Connie Morella; LA, Ileana Ros-Lehtinen

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.